A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
This is an observational study to confirm the presence of recurrent or persistent endogenous Cushing's syndrome in patients who have had primary surgical and/or radiation therapy for Cushing's disease and continue to manifest symptoms and signs of hypercortisolemia.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||A Study to Confirm the Presence of Recurrent or Persistent Cushing's Syndrome in Patients With Clinical Signs or Symptoms of Hypercortisolemia Who Have Been Treated for Cushing's Disease|
- To confirm the presence of recurrent or persistent endogenous Cushing's syndrome in patients who have had primary surgical and/or radiation therapy for Cushing's disease and continue to manifest symptoms and signs of hypercortisolemia. [ Time Frame: up to 16 weeks ] [ Designated as safety issue: No ]
|Study Start Date:||February 2009|
|Primary Completion Date:||June 2010 (Final data collection date for primary outcome measure)|
Patients with presumed Cushing's disease who have failed pituitary surgery and/or radiation and require medical treatment for recurrent or persistent Cushing's syndrome.
Drug: Cushing's syndrome confirmation
Other Name: Provide access to standard test procedures.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00796783
|United States, California|
|AMCR Institute Inc.|
|Escondido, California, United States, 92026|
|United States, Florida|
|The Center for Diabetes and Endocrine Care|
|Hollywood, Florida, United States, 33021|
|United States, Texas|
|Diabetes and Glandular Disease Research|
|San Antonio, Texas, United States, 78229|
|Study Director:||Coleman Gross, MD||Corcept Therapeutics|